Table 3.
Functional relevance of regulated genes | Gene | Description | Public ID | Fold changea |
||
---|---|---|---|---|---|---|
PHH1b | PHH2b | PHH3b | ||||
Positive APR | ||||||
Major APR | CRPc | C-reactive protein, pentraxin-related | NM_000567 | 9.2 I | 45 I | 512 I |
SAA1 | Serum amyloid 1 | NM_000331 | 2 I | 4.3 I | 2.5 I | |
SAA2 | Serum amyloid 2 | NM_030754 | 2.3 I | 11.3 I | 3 I | |
APCS | Amyloid P component, serum | NM_001639 | 2 I | 2.5 I | 1.6 I | |
Coagulation proteins | FGA | Fibrinogen alpha chain | NM_000508 | 2.6 I | 7.5 I | 4.6 I |
FGB | Fibrinogen beta chain | NM_005141 | 1.6 I | 2.1 I | 1.7 I | |
FGG | Fibrinogen gamma chain | NM_000509 | 1.7 I | 2.3 I | 1.6 I | |
FGL-1 | Fibrinogen-like protein | NM_004467 | 2.3 I | 2.5 I | 2.5 I | |
Metal-binding proteins | HP | Haptoglobin | NM_005143 | 1.9 I | 1.7 I | 2 I |
HPR | Haptoglobin-related protein | NM_020995 | 2.6 I | 1.7 I | 2.3 I | |
Mn-SODc | Superoxide dismutase 2, mitochondrial | NM_000636 | 2 I | 3.7 I | 4.3 I | |
Proteinase inhibitors | SERPINA 1 | Serpin peptidase inhibitor, clade A, member 1, anti-trypsin | NM_000295 | 1.8 I | 1.4 I | 1.9 I |
SERPINA 3 | Serpin peptidase inhibitor, clade A, member 3, anti-trypsin | NM_001085 | 2.1 I | 2.2 I | 2 I | |
Complement proteins | C4A | Complement component 4A | NM_007293 | 2.8 I | nc | 3 I |
C9 | Complement component 9 | NM_001737 | 3.2 I | 3.7 I | 16 I | |
Other proteins | LBP | Lipopolysaccharide-binding protein | NM_004139 | 4.3 I | 8 I | 9.2 I |
ORM1 | Orosomucoid 1 | NM_000607 | 2.7 I | 2.3 I | 3.2 I | |
ORM2 | Orosomucoid 2 | NM_000608 | 2.3 I | 1.8 I | 5.3 I | |
Negative APR | ALB | Albumin | NM_000477 | nc | –2.5 D | –1.6 D |
ITIH2 | Interalpha (globulin) inhibitor H2 | NM_002216 | nc | –2 D | –2.5 D | |
HRG | Histidine-rich protein | NM_000412 | nc | –6.1 D | –1.5 D | |
Chemokines | CXCL1 | Chemokine (C-X-C motif) ligand 1 | NM_001511 | 2.9 I | 15.3 I | 33 I |
CXCL2 | Chemokine (C-X-C motif) ligand 2 | NM_002089 | 1.5 I | 82 I | 8 I | |
CXCL5 | Chemokine (C-X-C motif) ligand 5 | NM_002994 | nc | 9.2 I | 7 I | |
CXCL6 | Chemokine (C-X-C motif) ligand 6 | NM_002993 | 1.7 I | 13.3 I | 29 I | |
CCL2c | Chemokine (C-C motif) ligand 2 | NM_002982 | 5.9 I | 11.9 I | 19.3 I | |
CCL20 | Chemokine (C-C motif) ligand 20 | NM_004591 | 1.7 I | 26.7 I | 6.7 I | |
Apoptosis | ||||||
Negative regulators | cIAP2 | cIAP2 apoptosis inhibitor 2, Birc3 | NM_001165 | nc | 4.9 I | 4.6 I |
IER3 | Immediate early response 3 | NM_003897 | nc | 4.4 I | 1.9 I | |
TNFAIP8 | Tumor necrosis factor-α–induced protein 8, FLIP-like, SCC-S2 | NM_014350 | nc | 2.5 I | 2.3 I | |
Mn-SOD | Superoxide dismutase 2, mitochondrial | NM_000636 | 2 I | 3.7 I | 4.3 I | |
PBEF1 | Pre–B-cell colony enhancing factor 1 | NM_005746 | nc | 2.3 I | 3.3 I | |
CRP | C-reactive protein, pentraxin-related | NM_000567 | 9.2 I | 45 I | 512 I | |
IL-8 | Interleukin 8 | NM_000584 | nc | 21 I | 8 I | |
CCL2 | Chemokine (C-C motif) ligand 2 | NM_002982 | 5.9 I | 11.9 I | 19.3 I | |
IGFBP1 | Insulin-like growth factor binding protein 1 | NM_000596 | nc | 113.8 I | 4.3 I | |
Positive regulators | APOEc | Apolipoprotein E | NM_000041 | nc | –10.5 D | –2.7 D |
CASP4 | Caspase 4 | NM_001225 | nc | 3.6 I | 1.8 I | |
Metabolism | ||||||
Antioxidant proteins | Mn-SOD | Superoxide dismutase 2, mitochondrial | NM_000636 | 2 I | 3.7 I | 3.7 I |
GPX2 | Glutathione peroxidase 2 | NM_002083 | 5.1 I | 3.1 I | 6.1 I | |
CP | Ceruloplasmin (ferroxidase) | NM_000096 | nc | 4.8 I | 7 I | |
Xenobiotic metabolism proteins | CYP3A4c | Cytochrome P450, Family 3, subfamily A, polypeptide 4 | NM_000776 | –2.8 D | –6.5 D | –7 D |
UGT2B15 | UDP glucuronosyltransferase 2 family, polypeptide B15 | NM_001076 | –2.3 D | –16 D | –13 D | |
UGT2B28 | UDP glucuronosyltransferase 2 family, polypeptide B28 | NM_053039 | nc | –6.4 D | –2.5 D | |
Oxydoreductases and electron transport proteins | CYP3A4 | Cytochrome P450, Family 3, subfamily A, polypeptide 4 | NM_000776 | –2.8 D | –6.5 D | –7 D |
CYP3A7 | Cytochrome P450, Family 3, subfamily A, polypeptide 7 | NM_000765 | –1.6 D | –2.5 D | –2 D | |
CYP2C8 | Cytochrome P450, Family 2, subfamily C, polypeptide 8 | NM_030878 | –1.6 D | –8 D | –4.4 D | |
CYP2A6 | Cytochrome P450, Family 2, subfamily A, polypeptide 6 | NM_000762 | nc | –4.9 D | –6.1 D | |
CYP2C9 | Cytochrome P450, Family 2, subfamily C, polypeptide 9 | NM_000771 | –2 D | –3.5 D | –5.7 D | |
CYP2C19 | Cytochrome P450, Family 2, subfamily C, polypeptide 19 | NM_000769 | –1.7 D | –5.3 D | –1.9 D | |
GRHPR | Glyoxylate reductase, hydroxypyruvate reductase | NM_012203 | nc | –2.5 D | –2.8 D | |
ACADL | Acyl-coenzyme A dehydrogenase, long chain | NM_001608 | –1.7 D | –2.6 D | –2 D | |
BDH | 3-hydroxybutyrate dehydrogenase | NM_004051 | nc | –1.9 D | –5.5 D | |
Lipid metabolism and transport proteins | APOE | Apolipoprotein E | NM_000041 | nc | –10.5 D | –2.7 D |
ACADL | Acyl-coenzyme A dehydrogenase, long chain | NM_001608 | –1.7 D | –2.6 D | –2 D | |
CYP3A4 | Cytochrome P450, Family 3, subfamily A, polypeptide 4 | NM_000776 | –2.8 D | –6.5 D | –7 D | |
AKR1B10 | Aldo-keto reductase family 7, member B10 | NM_020299 | –3 D | –1.4 D | –4 D |
APR, acute phase response; HBV, hepatitis B virus; PHH, primary human hepatocyte.
increased (I), decreased (D), or no change (nc) in gene expression in HBV-infected PHH compared to mock-infected cells.
PHH prepared from different patients (1-3).
Due to the dual functions, some of genes are listed twice.